Celltrion
068270.KS
#741
Rank
โ‚น2.272 T
Marketcap
โ‚น10,558
Share price
0.33%
Change (1 day)
-23.80%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

EPS for Celltrion (068270.KS)

EPS in 2023 (TTM): โ‚น245.26

According to Celltrion 's latest financial reports the company's current EPS (TTM) is โ‚น256.53. In 2022 the company made an earnings per share (EPS) of โ‚น249.74 a decrease over its 2021 EPS that were of โ‚น296.75.

EPS history for Celltrion from 2007 to 2023

Annual EPS

Year EPS Change
2023 (TTM)โ‚น245.26-1.79%
2022โ‚น249.74-15.84%
2021โ‚น296.7512.77%
2020โ‚น263.1470.79%
2019โ‚น154.0715.63%
2018โ‚น133.25-33.13%
2017โ‚น199.27141.17%
2016โ‚น82.638.28%
2015โ‚น76.3111.28%
2014โ‚น68.5816.37%
2013โ‚น58.93-67.42%
2012โ‚น180.9084.22%
2011โ‚น98.2062.13%
2010โ‚น60.5780.61%
2009โ‚น33.53-559.63%
2008-โ‚น7.30-123.16%
2007โ‚น31.50